Financial Information for the Company and Its Subsidiaries (Tables)

3 Months Ended

Mar. 31, 2015

Condensed Financial Information of Parent Company Only Disclosure [Abstract]



Condensed Consolidating Balance Sheet - March 31, 2015 (In thousands)
	Parent Issuer		Guarantor Subsidiaries		Non-Guarantor Subsidiaries		Consolidating Adjustments			Total Consolidated
Assets
Current assets:
Cash and cash equivalents	$	30,118	$	38,681	$	47,357	$	—		$	116,156
Restricted cash and marketable securities	—		—		10,957		—			10,957
Accounts receivable, net	—		130,807		113,195		—			244,002
Supplies inventory	—		286		20,187		—			20,473
Prepaid and other current assets	51,155		32,196		19,729		(5,719		)	97,361
Total current assets	81,273		201,970		211,425		(5,719		)	488,949
Property and equipment, net	11,910		8,665		162,871		—			183,446
Investments in and receivables from unconsolidated affiliates	4,025,683		1,635,845		—		(5,582,217		)	79,311
Goodwill	—		1,549,964		—		1,950,704			3,500,668
Intangible assets, net	66,001		1,237,487		2,779		—			1,306,267
Other assets	3,734		1,040		20,594		—			25,368
Total assets	$	4,188,601	$	4,634,971	$	397,669	$	(3,637,232	)	$	5,584,009
Liabilities and Equity
Current liabilities:
Current portion of long-term debt	$	8,700	$	—	$	10,158	$	—		$	18,858
Accounts payable	2,255		224		28,256		(4,927		)	25,808
Accrued salaries and benefits	19,652		111,525		13,430		—			144,607
Accrued interest	17,840		—		17		—			17,857
Other accrued liabilities	7,272		39,909		29,312		(792		)	75,701
Total current liabilities	55,719		151,658		81,173		(5,719		)	282,831
Long-term debt	2,204,775		—		56,204		(30,985		)	2,229,994
Deferred income taxes	218,564		429,880		—		—			648,444
Other long-term liabilities	7,867		65,622		18,996		—			92,485
Intercompany payable	—		1,228,136		21		(1,228,157		)	—
Noncontrolling interests – redeemable	—		—		62,793		120,666			183,459
Equity:
Total AmSurg Corp. equity	1,701,676		2,759,675		132,731		(2,892,406		)	1,701,676
Noncontrolling interests – non-redeemable	—		—		45,751		399,369			445,120
Total equity	1,701,676		2,759,675		178,482		(2,493,037		)	2,146,796
Total liabilities and equity	$	4,188,601	$	4,634,971	$	397,669	$	(3,637,232	)	$	5,584,009



Condensed Consolidating Balance Sheet - December 31, 2014 (In thousands)
	Parent Issuer		Guarantor Subsidiaries		Non-Guarantor Subsidiaries		Consolidating Adjustments			Total Consolidated
Assets
Current assets:
Cash and cash equivalents	$	134,351	$	23,471	$	50,257	$	—		$	208,079
Restricted cash and marketable securities	—		—		10,219		—			10,219
Accounts receivable, net	—		123,772		109,281		—			233,053
Supplies inventory	—		301		19,673		—			19,974
Prepaid and other current assets	47,997		58,388		13,795		(4,818		)	115,362
Total current assets	182,348		205,932		203,225		(4,818		)	586,687
Property and equipment, net	10,391		9,972		160,085		—			180,448
Investments in and receivables from unconsolidated affiliates	3,912,804		1,587,881		—		(5,425,210		)	75,475
Goodwill	—		1,490,981		—		1,890,168			3,381,149
Intangible assets, net	67,678		1,203,218		2,983		—			1,273,879
Other assets	3,323		943		23,086		(1,466		)	25,886
Total assets	$	4,176,544	$	4,498,927	$	389,379	$	(3,541,326	)	$	5,523,524
Liabilities and Equity
Current liabilities:
Current portion of long-term debt	$	8,700	$	—	$	10,126	$	—		$	18,826
Accounts payable	1,849		35		31,781		(4,080		)	29,585
Accrued salaries and benefits	25,035		101,395		13,614		—			140,044
Accrued interest	29,621		—		23		—			29,644
Other accrued liabilities	8,051		44,305		16,368		(738		)	67,986
Total current liabilities	73,256		145,735		71,912		(4,818		)	286,085
Long-term debt	2,206,950		—		53,648		(28,412		)	2,232,186
Deferred income taxes	209,400		425,546		—		(1,466		)	633,480
Other long-term liabilities	7,391		63,616		18,436		—			89,443
Intercompany payable	—		1,219,979		8,010		(1,227,989		)	—
Noncontrolling interests – redeemable	—		—		63,544		120,555			184,099
Equity:
Total AmSurg Corp. equity	1,679,547		2,644,051		130,206		(2,774,257		)	1,679,547
Noncontrolling interests – non-redeemable	—		—		43,623		375,061			418,684
Total equity	1,679,547		2,644,051		173,829		(2,399,196		)	2,098,231
Total liabilities and equity	$	4,176,544	$	4,498,927	$	389,379	$	(3,541,326	)	$	5,523,524

Condensed Consolidating Statement of Operations



Condensed Consolidating Statement of Earnings - For the Three Months Ended March 31, 2015 (In thousands)
	Parent Issuer			Guarantor Subsidiaries			Non-Guarantor Subsidiaries			Consolidating Adjustments			Total Consolidated
Net revenue	$	7,091		$	285,579		$	286,629		$	(8,854	)	$	570,445
Operating expenses:
Salaries and benefits	17,643			211,601			73,063			(128		)	302,179
Supply cost	—			396			42,188			—			42,584
Other operating expenses	6,634			29,611			63,051			(8,726		)	90,570
Transaction costs	268			1,203			—			—			1,471
Depreciation and amortization	834			14,307			7,677			—			22,818
Total operating expenses	25,379			257,118			185,979			(8,854		)	459,622
Loss on deconsolidation	(188		)	(188		)	(35		)	188			(223		)
Equity in earnings of unconsolidated affiliates	60,387			54,583			—			(112,319		)	2,651
Operating income	41,911			82,856			100,615			(112,131		)	113,251
Interest expense, net	11,886			17,754			607			—			30,247
Earnings from operations before income taxes	30,025			65,102			100,008			(112,131		)	83,004
Income tax expense	8,987			4,903			359			—			14,249
Net earnings	21,038			60,199			99,649			(112,131		)	68,755
Net earnings attributable to noncontrolling interests	—			—			47,717			—			47,717
Net earnings attributable to AmSurg Corp. shareholders	21,038			60,199			51,932			(112,131		)	21,038
Preferred stock dividends	(2,264		)	—			—			—			(2,264		)
Net earnings attributable to AmSurg Corp. common shareholders	$	18,774		$	60,199		$	51,932		$	(112,131	)	$	18,774



Condensed Consolidating Statement of Earnings - For the Three Months Ended March 31, 2014 (In thousands)
	Parent Issuer			Guarantor Subsidiaries		Non-Guarantor Subsidiaries		Consolidating Adjustments			Total Consolidated
Net revenue	$	6,127		$	—	$	258,043	$	(4,609	)	$	259,561
Operating expenses:
Salaries and benefits	14,485			—		67,785		(121		)	82,149
Supply cost	—			—		37,805		—			37,805
Other operating expenses	4,166			—		54,491		(4,488		)	54,169
Depreciation and amortization	825			—		7,434		—			8,259
Total operating expenses	19,476			—		167,515		(4,609		)	182,382
Gain on deconsolidation	2,045			2,045		—		(2,045		)	2,045
Equity in earnings of unconsolidated affiliates	48,052			48,052		—		(95,340		)	764
Operating income	36,748			50,097		90,528		(97,385		)	79,988
Interest expense	6,452			—		508		—			6,960
Earnings from continuing operations before income taxes	30,296			50,097		90,020		(97,385		)	73,028
Income tax expense	12,704			—		278		—			12,982
Net earnings from continuing operations	17,592			50,097		89,742		(97,385		)	60,046
Net earnings (loss) from discontinued operations	(397		)	—		465		—			68
Net earnings	17,195			50,097		90,207		(97,385		)	60,114
Net earnings attributable to noncontrolling interests	—			—		42,919		—			42,919
Net earnings attributable to AmSurg Corp. common shareholders	$	17,195		$	50,097	$	47,288	$	(97,385	)	$	17,195
Amounts attributable to AmSurg Corp. common shareholders:
Earnings from continuing operations, net of income tax	$	17,592		$	50,097	$	47,088	$	(97,385	)	$	17,392
Discontinued operations, net of income tax	(397		)	—		200		—			(197		)
Net earnings attributable to AmSurg Corp. common shareholders	$	17,195		$	50,097	$	47,288	$	(97,385	)	$	17,195

Condensed Consolidating Statement of Cash Flows



Condensed Consolidating Statement of Cash Flows - For the Three Months Ended March 31, 2015 (In thousands)
	Parent Issuer			Guarantor Subsidiaries			Non-Guarantor Subsidiaries			Consolidating Adjustments			Total Consolidated
Cash flows from operating activities:
Net cash flows provided by (used in) operating activities	$	(33,779	)	$	91,981		$	102,821		$	(62,196	)	$	98,827
Cash flows from investing activities:
Acquisitions and related expenses	(62,056		)	(127,047		)	—			62,525			(126,578		)
Acquisition of property and equipment	(2,678		)	(2,538		)	(9,567		)	—			(14,783		)
Other	—			(1,322		)	1,102			—			(220		)
Net cash flows used in investing activities	(64,734		)	(130,907		)	(8,465		)	62,525			(141,581		)
Cash flows from financing activities:
Proceeds from long-term borrowings	—			—			2,227			—			2,227
Repayment on long-term borrowings	(2,175		)	—			(3,038		)	—			(5,213		)
Distributions to owners, including noncontrolling interests	—			(10,241		)	(99,157		)	62,196			(47,202		)
Capital contributions	—			62,056			—			(62,056		)	—
Cash dividends for preferred shares	(2,264		)	—			—			—			(2,264		)
Changes in intercompany balances with affiliates, net	(2,573		)	—			2,573			—			—
Other financing activities, net	1,292			2,321			139			(469		)	3,283
Net cash flows provided by (used in) financing activities	(5,720		)	54,136			(97,256		)	(329		)	(49,169		)
Net increase (decrease) in cash and cash equivalents	(104,233		)	15,210			(2,900		)	—			(91,923		)
Cash and cash equivalents, beginning of period	134,351			23,471			50,257			—			208,079
Cash and cash equivalents, end of period	$	30,118		$	38,681		$	47,357		$	—		$	116,156



Condensed Consolidating Statement of Cash Flows - For the Three Months Ended March 31, 2014 (In thousands)
	Parent Issuer			Guarantor Subsidiaries			Non-Guarantor Subsidiaries			Consolidating Adjustments			Total Consolidated
Cash flows from operating activities:
Net cash flows provided by operating activities	$	18,482		$	48,096		$	96,257		$	(93,016	)	$	69,819
Cash flows from investing activities:
Acquisitions and related expenses	—			(5,082		)	—			44			(5,038		)
Acquisition of property and equipment	(1,237		)	—			(5,801		)	—			(7,038		)
Proceeds from sale of interests in surgery centers	—			1,111			—			—			1,111
Other	(629		)	211			—			—			(418		)
Net cash flows used in investing activities	(1,866		)	(3,760		)	(5,801		)	44			(11,383		)
Cash flows from financing activities:
Proceeds from long-term borrowings	30,000			—			1,945			—			31,945
Repayment on long-term borrowings	(47,679		)	—			(3,174		)	—			(50,853		)
Distributions to owners, including noncontrolling interests	—			(44,920		)	(91,290		)	93,016			(43,194		)
Changes in intercompany balances with affiliates, net	556			—			(556		)	—			—
Other financing activities, net	(641		)	584			43			(44		)	(58		)
Net cash flows used in financing activities	(17,764		)	(44,336		)	(93,032		)	92,972			(62,160		)
Net decrease in cash and cash equivalents	(1,148		)	—			(2,576		)	—			(3,724		)
Cash and cash equivalents, beginning of period	6,710			—			44,130			—			50,840
Cash and cash equivalents, end of period	$	5,562		$	—		$	41,554		$	—		$	47,116